06:28 AM EST, 11/13/2024 (MT Newswires) -- Travere Therapeutics ( TVTX ) said Wednesday it has completed a public offering of 9.0 million shares of common stock at a price to the public of $16.00 per share, including 1.2 million shares sold as part of the underwriters' option to purchase additional shares, for gross proceeds of around $143.8 million.